107 related articles for article (PubMed ID: 22038782)
1. Xanthoangelols isolated from Angelica keiskei inhibit inflammatory-induced plasminogen activator inhibitor 1 (PAI-1) production.
Ohkura N; Nakakuki Y; Taniguchi M; Kanai S; Nakayama A; Ohnishi K; Sakata T; Nohira T; Matsuda J; Baba K; Atsumi G
Biofactors; 2011; 37(6):455-61. PubMed ID: 22038782
[TBL] [Abstract][Full Text] [Related]
2. Ashitaba (Angelica Keiskei) Exudate Prevents Increases in Plasminogen Activator Inhibitor-1 Induced by Obesity in Tsumura Suzuki Obese Diabetic Mice.
Ohta M; Fujinami A; Oishi K; Kobayashi N; Ohnishi K; Ohkura N
J Diet Suppl; 2019; 16(3):331-344. PubMed ID: 29708806
[TBL] [Abstract][Full Text] [Related]
3. Anti-platelet effects of chalcones from
Ohkura N; Ohnishi K; Taniguchi M; Nakayama A; Usuba Y; Fujita M; Fujii A; Ishibashi K; Baba K; Atsumi G
Pharmazie; 2016 Nov; 71(11):651-654. PubMed ID: 29441970
[TBL] [Abstract][Full Text] [Related]
4. Angelica keiskei (Ashitaba) powder and its functional compound xanthoangelol prevent heat stress-induced impairment in sperm density and quality in mouse testes.
Kokubu D; Ooba R; Abe Y; Ishizaki H; Yoshida S; Asano A; Kashiwabara SI; Miyazaki H
J Reprod Dev; 2019 Apr; 65(2):139-146. PubMed ID: 30686791
[TBL] [Abstract][Full Text] [Related]
5. Absorption and metabolism of 4-hydroxyderricin and xanthoangelol after oral administration of Angelica keiskei (Ashitaba) extract in mice.
Nakamura T; Tokushima T; Kawabata K; Yamamoto N; Miyamoto M; Ashida H
Arch Biochem Biophys; 2012 May; 521(1-2):71-6. PubMed ID: 22452965
[TBL] [Abstract][Full Text] [Related]
6. Bioassay-guided isolation and identification of anti-platelet-active compounds from the root of Ashitaba (Angelica keiskei Koidz.).
Son DJ; Park YO; Yu C; Lee SE; Park YH
Nat Prod Res; 2014; 28(24):2312-6. PubMed ID: 25019280
[TBL] [Abstract][Full Text] [Related]
7. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
Kimura Y; Taniguchi M; Baba K
Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
[TBL] [Abstract][Full Text] [Related]
8. Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: Isolation of an active substance, xanthoangelol.
Kimura Y; Baba K
Int J Cancer; 2003 Sep; 106(3):429-37. PubMed ID: 12845685
[TBL] [Abstract][Full Text] [Related]
9. Artery relaxation by chalcones isolated from the roots of Angelica keiskei.
Matsuura M; Kimura Y; Nakata K; Baba K; Okuda H
Planta Med; 2001 Apr; 67(3):230-5. PubMed ID: 11345693
[TBL] [Abstract][Full Text] [Related]
10. Six new chalcones from Angelica keiskei inducing adiponectin production in 3T3-L1 adipocytes.
Ohnogi H; Kudo Y; Tahara K; Sugiyama K; Enoki T; Hayami S; Sagawa H; Tanimura Y; Aoi W; Naito Y; Kato I; Yoshikawa T
Biosci Biotechnol Biochem; 2012; 76(5):961-6. PubMed ID: 22738967
[TBL] [Abstract][Full Text] [Related]
11. Supplementation with Ashitaba (
Ohkura N; Morimoto-Kamata R; Oishi K; Higo-Yamamoto S; Fujinami A; Inoue KI; Ohta M
J Med Food; 2023 Nov; 26(11):843-848. PubMed ID: 37862040
[No Abstract] [Full Text] [Related]
12. Beneficial effect of xanthoangelol, a chalcone compound from Angelica keiskei, on lipid metabolism in stroke-prone spontaneously hypertensive rats.
Ogawa H; Okada Y; Kamisako T; Baba K
Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):238-43. PubMed ID: 17250645
[TBL] [Abstract][Full Text] [Related]
13. 4-Hydroxyderricin and xanthoangelol isolated from Angelica keiskei prevent dexamethasone-induced muscle loss.
Yoshioka Y; Samukawa Y; Yamashita Y; Ashida H
Food Funct; 2020 Jun; 11(6):5498-5512. PubMed ID: 32510085
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic activities of oroxylin A in vitro and in vivo.
Ku SK; Lee IC; Bae JS
Arch Pharm Res; 2014 May; 37(5):679-86. PubMed ID: 23963976
[TBL] [Abstract][Full Text] [Related]
15. Possible antithrombotic effects of
Ohkura N; Atsumi G; Ohnishi K; Baba K; Taniguchi M
Pharmazie; 2018 Jun; 73(6):315-317. PubMed ID: 29880082
[TBL] [Abstract][Full Text] [Related]
16. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells.
Hu XY; Ma YH; Wang C; Yang YH
Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor-promotion by principles obtained from Angelica keiskei.
Okuyama T; Takata M; Takayasu J; Hasegawa T; Tokuda H; Nishino A; Nishino H; Iwashima A
Planta Med; 1991 Jun; 57(3):242-6. PubMed ID: 1896522
[TBL] [Abstract][Full Text] [Related]
18. Toxicological assessment of Ashitaba Chalcone.
Maronpot RR
Food Chem Toxicol; 2015 Mar; 77():111-9. PubMed ID: 25576957
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
Hamaguchi E; Takamura T; Shimizu A; Nagai Y
J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic activities of chalcones isolated from a Japanese Herb, Angelica keiskei.
Enoki T; Ohnogi H; Nagamine K; Kudo Y; Sugiyama K; Tanabe M; Kobayashi E; Sagawa H; Kato I
J Agric Food Chem; 2007 Jul; 55(15):6013-7. PubMed ID: 17583349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
